Amsterdam, NL – Although there is a growing trend to involve patients in clinical research, specific guiding principles for engaging individuals with Parkinson...
Galway, Ireland – New research from NUI Galway and Boston University has identified a blood biomarker that could help identify people with the earliest signs of...
Reading, UK – Alzheimer’s disease could be caused by damage to a protective barrier in the body that allows fatty substances to build up in the brain, newly...
Amsterdam, NL – A team from Spaulding Rehabilitation Hospital shares its experiences and successes designing and implementing a multidisciplinary clinical...
Amsterdam, NL – The diagnosis of Parkinson’s disease (PD) is currently based on consensus clinical criteria. A novel study reported in the Journal of Parkinson...
Toronto, ON, Canada – A new study led by a Baycrest clinician-scientist titled “Enhancing Clinical Visibility of Hearing Loss in Cognitive Decline” demonstrates...
St. Louis, MO, USA – Alzheimer’s disease usually is diagnosed based on symptoms, such as when a person shows signs of memory loss and difficulty thinking. Up...
Amsterdam, NL – Functional Movement Disorders (FMDs) are common and disabling conditions. With an increasing research interest in FMDs, including the emergence...
Amsterdam, NL – Vestibular symptoms such as vertigo, dizziness, and unsteadiness are commonly encountered in doctors’ offices and emergency rooms, but it is...
Amsterdam, NL – There is currently no effective treatment for facioscapulohumeral muscular dystrophy (FSHD), one of the most common neuromuscular diseases...
Champaign, IL, USA – A new study on culture and cognition found that long-term Hispanic immigrants who were less acculturated to the US performed significantly...
